ETF profile for iShares Biotechnology ETF (IBB) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
IBB ETF Profile
| Family: |
Blackrock (iShares) |
| Name: |
iShares Biotechnology ETF |
|
|
| Inception Date: |
5-Feb-2001 |
| Termination Date: |
|
| Investment Objective: |
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. It provides exposure to U.S. companies in the biotechnology industry. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| GILEAD SCIENCES |
GILD |
8.5747% |
| AMGEN INC |
AMGN |
8.2121% |
| VERTEX PHARMACEUTICALS |
VRTX |
7.7343% |
| REGENERON PHARMACEUTICALS |
REGN |
5.6749% |
| MODERNA |
MRNA |
5.1996% |
| NATERA |
NTRA |
3.8684% |
| ARGENX SE ADR |
ARGX |
3.4540% |
| ILLUMINA INC |
ILMN |
2.8861% |
| BIOGEN |
BIIB |
2.6151% |
| REVOLUTION MEDICINES |
RVMD |
2.5642% |
|
Top 10 Holdings Weight: |
50.8% |
| Number of Holdings: |
249 |
| Shares Outstanding: |
51,650,000 |
| Total Net Assets: |
10,729,771,008 |
| NAV: |
207.72 |
| Net Expense Ratio: |
0.44% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Large & Mid Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |
